Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venture Capital
Biotech
Fierce Biotech Fundraising Tracker '26: Abcuro, InduPro & more
Welcome to Fierce Biotech’s Fundraising Tracker for 2026.
Will Maddox
,
Darren Incorvaia
,
James Waldron
,
Gabrielle Masson
,
Marissa Russo
Aug 18, 2026 8:50am
Slate uses Fulcrum to join Nasdaq with $245M for migraine trials
Aug 17, 2026 9:30am
Pfizer vet debuts Khartis with sights set on thyroid eye disease
Aug 13, 2026 9:00am
Epicrispr bags $90M to rewrite treatment of rare muscle disease
Aug 11, 2026 10:30am
Regeneron backs $75M series A for antibody upstart Infinimmune
Aug 11, 2026 8:00am
Vaderis' $152M to fund ph. 3 trial in rare blood vessel disorder
Aug 11, 2026 7:00am